Core Viewpoint - Shanghai Ladder Medical Technology Co., Ltd. has completed a strategic financing round of 500 million RMB, led by Alibaba, to support the development of brain-machine interface and neural modulation technologies [2][3]. Company Overview - Shanghai Ladder Medical Technology Co., Ltd. focuses on the research and clinical application of invasive brain-machine interface systems and related neural modulation devices, particularly in the areas of brain-machine interface medical applications and neural function reconstruction [3]. Product and Technology Summary - The company is developing an invasive brain-machine interface system (WRS02) designed for brain signal acquisition and brain-controlled interaction applications. This system features a 256-channel wireless high-throughput interface and has entered the special review process for innovative medical devices by the National Medical Products Administration. Clinical implantation and functional validation were completed in early 2026, with plans for multi-center registration clinical trials within the year [4][5]. - The deep brain stimulation system (DBS) is aimed at treating neurological disorders such as Parkinson's disease and epilepsy, utilizing closed-loop neural modulation technology. Initial clinical research implantation has been completed, with further clinical trials planned [7]. Financing History - The financing history of the company includes: - March 13, 2026: B+ round, 500 million RMB led by Alibaba [8]. - December 17, 2025: B+ round led by Shanghai Guotou Pioneer Private Fund Management Co., Ltd. [8]. - February 10, 2025: B round, 350 million RMB led by Qiming Venture Partners [8]. - December 30, 2022: A round, several hundred million RMB led by Yuanhe Origin [8]. - December 19, 2022: Angel round, several million RMB led by Source Capital [8]. Patent Situation - The company holds several patents related to its technologies, including: - A flexible electrode for spinal cord applications, authorized on March 10, 2026 [10]. - Various implantable devices and methods for electrode implantation, with several patents granted and pending [10].